<style face="normal" font="default" size="100%">Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): A randomized, double-blind, placebo-control</style>

Drupal-Bibcite

0<style face="normal" font="default" size="100%">Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): A randomized, double-blind, placebo-control</style><style face="normal" font="default" size="100%">Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA<sup>®</sup>): A randomized, double-blind, placebo-control</style>